We’re building a UK-wide site network dedicated to psychiatry and CNS trials to help CROs and sponsors address increasing study complexity, timeline pressures, and recruitment challenges.
Sponsors can run large-scale trials with full control, ease and consistency as centralised functions drive efficiencies.
Our site network offers
Faster and more representative patient recruitment
Unmatched operational consistency
Fast-tracked site selection, set up and trial initiation
Single point of contracting
Access to experienced investigators, doctors and central raters
Therapeutic expertise
Psychiatry
Depression, PTSD, Anxiety Disorders, Eating Disorders, Substance Use Disorders, ADHD, Autism Spectrum Disorder
CNS
Pain, Parkinson’s Disease, Alzheimer’s Disease, Dementia
Our Trial Sites in London
The prime location for psychiatry and CNS trials
1. Welbeck Street
Capacity: 3 treatment rooms
2. Baker Street
Capacity: 6 treatment rooms
Sites 3, 4, and 5 are opening by the end of 2025.
20m live within 1.5h of our trial sites
56% of Londoners don’t identify as White British
>10 hospitals we’re currently able to recruit from
Schedule 1-4 Home Office licensed pharmacy
6 PIs, 10 doctors, >40 therapists and central raters
15 CNS & psychiatry conditions we have worked across
Our Principal Investigators (PIs)
Combined experience of 75 years in 20+ indications
Dr Iain Jordan
Psychiatry
20 years as Consultant Psychiatrist with past 10 years at Oxford University Hospital NHS FT. Also Hon. Sen. Lecturer at University of Oxford.
Trial experience: 11 years
Speciality: Psychosis, anxiety, trauma
Drugs: Psychedelics
Dr Simon Vann Jones
CNS
Consultant Psychiatrist at Complex Care & Dementia and Cornwall Partnership NHS. Also NIHR Dementia Speciality Research Lead at SW Peninsula.
Trial experience: 11 years
Specialty: Dementia, Parkinson's
Drugs: NMDA agonists, digital therapeutics, ketone supplements, SSRIs, cognitive enhancers
Dr Paul Morrison
Psychiatry
20 years experience in pharmacology & psychiatry. Hon. Sen. Lecturer at King’s College London. Designed numerous trials with >200 participants.
Trial experience: 16 years
Speciality: Psychosis, TRD, Addiction
Drugs: Psychedelics, cannabinoids
Dr Mallika Pullukoglu
CNS & Psychiatry
Consultant Psychiatrist and Hon. Sen. Lecturer at Uni. of Glasgow, with 17 years experience in mental health. Led NHS and commercial trials as Sen. Researcher.
Trial experience: 11 years
Speciality: ADHD, ASD, Addiction, MDD
Drugs: GABA agonists, psychotropic solutions, psychedelics, cannabinoids
Dr Babatunde Oyesile
CNS & Psychiatry
Principal, Chief, and National lead to 120 trials at leading CROs and hospitals in the last decade. Also medical monitoring expert.
Trial experience: 14 years
Speciality: Cardiovascular, pain, CNS
Drugs: Migraine, Monoclonal antibodies, Bone health, Lipid-lowering, ARBs, Beta-agonists
Dr Liliana Galindo Guarin
Psychiatry
Affil. Asst. Professor at University of Cambridge. Also Medical Leader in Psychosis at Cambridgeshire & Peterborough NHS FT.
Trial experience: 12 years
Speciality: Psychosis, PTSD, Insomnia
Drugs: Cathinones, enzyme inhibitors, antipsychotics, psychedelics, cannabinoids
3-10x
Faster recruitment compared to other sites
2 weeks
Between sponsor greenlight and first patient screened
93%
Enrolled participant retention
6
PIs with combined experience of 75 years in 20+ indication
>30,000
Vetted UK patient database
>40
Trained therapists